0002019976-25-000002.txt : 20250205 0002019976-25-000002.hdr.sgml : 20250205 20250205163043 ACCESSION NUMBER: 0002019976-25-000002 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20250203 FILED AS OF DATE: 20250205 DATE AS OF CHANGE: 20250205 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Novack Jeffrey Adam CENTRAL INDEX KEY: 0002019976 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36536 FILM NUMBER: 25593771 MAIL ADDRESS: STREET 1: 8000 MARINA BOULEVARD CITY: BRISBANE STATE: CA ZIP: 94005 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CareDx, Inc. CENTRAL INDEX KEY: 0001217234 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 943316839 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 8000 MARINA BLVD STREET 2: 4TH FLOOR CITY: BRISBANE STATE: CA ZIP: 94005 BUSINESS PHONE: 415-287-2300 MAIL ADDRESS: STREET 1: 8000 MARINA BLVD STREET 2: 4TH FLOOR CITY: BRISBANE STATE: CA ZIP: 94005 FORMER COMPANY: FORMER CONFORMED NAME: XDx, Inc. DATE OF NAME CHANGE: 20071010 FORMER COMPANY: FORMER CONFORMED NAME: EXPRESSION DIAGNOSTICS INC DATE OF NAME CHANGE: 20030203 4 1 wk-form4_1738791038.xml FORM 4 X0508 4 2025-02-03 0 0001217234 CareDx, Inc. CDNA 0002019976 Novack Jeffrey Adam C/O CAREDX, INC. 8000 MARINA BOULEVARD BRISBANE CA 94005 0 1 0 0 Secretary and General Counsel 1 Common Stock 2025-02-03 4 F 0 2048 23.32 D 108189 D Common Stock 2025-02-04 4 S 0 3512 23.2999 D 104677 D These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units. The transaction reported in this row was effected pursuant to a Rule 10b5-1 trading plan, adopted by the Reporting Person on August 19, 2024. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.1000 to $23.7300, inclusive. The Reporting Person undertakes to provide to CareDx, Inc., any security holder of CareDx, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4. /s/ Jeffrey Adam Novack 2025-02-05